BioUtah Selects Rich Linder As New Board Chair, George Hamilton As Vice Chair

BioUtah Selects Rich Linder As New Board Chair, George Hamilton As Vice Chair

BioUtah, the industry association for Utah's life science community, today announced the election of Richard J. Linder as chair of its executive board of directors, and George Hamilton as vice chair. Linder succeeds Merit CEO and founder Fred Lampropoulos, BioUtah's inaugural board chair. Nelson Labs CEO Jeff Nelson served as BioUtah's first vice chair.

Suggested Articles

Cancer biotech Zentalis Pharmaceuticals priced its IPO at $165 million, eclipsing the $100 million goal it laid out in early March.

The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based vaccine.

Johnson & Johnson is paying Fate Therapeutics $50 million upfront to collaborate on up to four CAR NK and CAR-T cell therapies.